<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cardiol Ther</journal-id><journal-id journal-id-type="iso-abbrev">Cardiol Ther</journal-id><journal-title-group><journal-title>Cardiology and Therapy</journal-title></journal-title-group><issn pub-type="ppub">2193-8261</issn><issn pub-type="epub">2193-6544</issn><publisher><publisher-name>Springer Healthcare</publisher-name><publisher-loc>Cheshire</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27995554</article-id><article-id pub-id-type="pmc">5446811</article-id><article-id pub-id-type="publisher-id">78</article-id><article-id pub-id-type="doi">10.1007/s40119-016-0078-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>A Randomized Trial to Assess the Contribution of a Novel Thorax Support Vest (Corset) in Preventing Mechanical Complications of Median Sternotomy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Caimmi</surname><given-names>Philippe P.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Sabbatini</surname><given-names>Maurizio</given-names></name><address><email>maurizio.sabbatini@uniupo.it</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kapetanakis</surname><given-names>Emmanouil I.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Cantone</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Ferraz</surname><given-names>Marcus V.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Cannas</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Tesler</surname><given-names>Ugo F.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label>Department of Cardiac Surgery, University Hospital of Novara &#x0201c;Maggiore della Carit&#x000e0;&#x0201d;, Novara, Italy </aff><aff id="Aff2"><label>2</label>Department of Science Health, UPO University, Novara, Italy </aff><aff id="Aff3"><label>3</label>&#x0201c;Policlinico di Monza&#x0201d; Hospital Group, Department Cardiac Surgery, San Gaudenzio Clinic, Novara, Italy </aff><aff id="Aff4"><label>4</label>Department of Science and Innovation Technology, UPO University, Alessandria, Italy </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.416145.3</institution-id><institution>Department of Thoracic Surgery, </institution><institution>&#x0201c;Sotiria&#x0201d; Chest Diseases Hospital of Athens, </institution></institution-wrap>Athens, Greece </aff><aff id="Aff6"><label>6</label>&#x0201c;Policlinico di Monza&#x0201d; Health Care Group, Department Cardiac Anaestehsiology, San Gaudenzio Clinic, Novara, Italy </aff><aff id="Aff7"><label>7</label>Department of Cardiac Surgery, Beneficencia Portouguesa Hospital, Piracicaba, Brazil </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2017</year></pub-date><volume>6</volume><issue>1</issue><fpage>41</fpage><lpage>51</lpage><history><date date-type="received"><day>1</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2016</copyright-statement></permissions><abstract id="Abs1"><sec><title>Objectives</title><p>Mechanical complications of median sternotomy may cause significant morbidity and mortality in cardiac surgical patients. This study was aimed at assessing the role of Posthorax support vest (Epple, Inc., Vienna, Austria) in the prevention of sternal complications and the improvement of anatomical healing in patients at high risk for mechanical sternal dehiscence after cardiac surgery by mean of median sternotomy.</p></sec><sec><title>Methods</title><p>A prospective, randomized, study was performed and 310 patients with predisposing factors for sternal dehiscence after sternotomy for cardiac surgery were included. The patients were divided into two groups: patients who received the Posthorax support vest after surgery, and patients who did not. Primary variables assessed included the incidence of mechanical sternal complications, the quality of sternal healing, the rate of re-operation, the duration of hospitalization, rate and duration of hospital, re-admission for sternal complications. Secondary variables assessed were the post-operative pain, the number of requests for supplemental analgesia and the quality of life measured by means of the EQ-5D format.</p></sec><sec><title>Results</title><p>Patients using vest demonstrated a lower incidence of mechanical sternal complications, a better anatomical sternum healing, lower hospital stay, no re-operations for sternal dehiscence before discharge and lower re-admissions for mechanical sternal complication. In addition, patients using a vest reported a better quality of life with better freedom from limitations in mobility, self-care, and pain.</p></sec><sec><title>Conclusions</title><p>Our findings demonstrate that the use of the Posthorax vest reduces post-sternotomy mechanical complications and improves the healing of the sternotomy, the clinical course, and the post-operative quality of life.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Postoperative care</kwd><kwd>Quality of life</kwd><kwd>Sternum</kwd><kwd>Surgery complications</kwd><kwd>Wound healing</kwd><kwd>Dehiscence</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Healthcare 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Mechanical complications of median sternotomy are less frequent than infective complications, but are a significant cause of morbidity and, occasionally, of mortality in patients undergoing cardiac surgery [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. These complications can lead to a prolonged hospitalization and sometimes require surgical sternum revision [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The increased utilization of resources in terms of the duration of hospitalization, staff work-hours, use of materials and of infrastructure, result in higher health care costs [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. The limitations imposed on the reimbursement of health care expenditures, especially in recent years, have heightened the importance of preventing post-sternotomy induced complications and the need to reduce re-admissions and mean hospitalization times whilst, at the same time, be able to provide the best patient recovery and subsequent quality of life [<xref ref-type="bibr" rid="CR4">4</xref>]. Furthermore, anatomically imperfect sternal healing may cause chronic pain and affect the chest mobility for many subsequent years [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>].</p><p>The present research has a particular focus on mechanical sternal dehiscence [<xref ref-type="bibr" rid="CR8">8</xref>], a topic only marginally treated by other papers [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>].</p><p>We have adopted the Posthorax support vest (Epple, Inc., Vienna, Austria) as its design stabilizes the sternum following sternotomy, relieves pressure on the suture wires and reduces pain when breathing, coughing, and during rehabilitation.</p><p>The aim of this study was to assess the prevention of mechanical complications of median sternotomy and the improvement of the anatomical sternum healing by means of the utilization of the Posthorax support vest and to evaluate its impact on in-hospital recovery in a group of patients at high risk for sternal dehiscence.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Eligibility Requirements and Recruitment</title><p>All procedures followed were in accordance with the ethical standards of the responsible national and institutional committee on human experimentation and with the Helsinki Declaration of 1964, as revised in 2013. Informed consent was obtained from all patients for being included in the study. From February 15, 2010, to September 15, 2014, a prospective, randomized, study was conducted. The CONSORT flow diagram [<xref ref-type="bibr" rid="CR12">12</xref>] was adopted in order to assess the number of eligible patients who underwent a cardiac surgical procedure with a median sternotomy (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). We assess for eligibility 2800 consecutive patients. Out of this group, 2490 patients were excluded and 310 patients were included for randomization. Exclusion criteria were the removal of the chest drains after the 4th post-operative day, the re-admission to the intensive care unit, the need for adoption of mechanical ventilation for any cause and the re-operation for non-mechanically induced complications of sternotomy including mediastinitis, wound, sternal infection, or secondary sternal wound infection and bleeding.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>The CONSORT diagram showing the flow of participants through each stage of a randomized study</p></caption><graphic xlink:href="40119_2016_78_Fig1_HTML" id="MO1"/></fig>
</p><p>Within the cohort of 310 patients, 155 patients were allocated in group A (GA), in whom the Posthorax support vest was used following the removal of the chest drains for their entire hospitalization and until 90&#x000a0;days after discharge, whereas the remaining 155 patients were allocated in group B (GB), in whom no support vests were used after surgery.</p><p>A power analysis was performed to determine the adequate sample size. Based on preliminary study results [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], and an estimated incidence of cumulative complication rates of 3% for group A and 10% for group B, we have obtained a power value of 0.7 with a sample size&#x000a0;of 152 patients.</p><p>The follow-up has been 100% complete and 100% of patients have been included in statistical analysis. Both groups had identical inclusion criteria and were deemed at high risk for mechanically induced sternal dehiscence if they presented at least one of the following recognized risk factors for complications of median sternotomy: any type of diabetes mellitus (regardless of duration of disease requiring diet modification, oral or insulin therapy), obesity [body mass index (BMI) &#x02265;25], bilateral internal mammary artery (BIMA) harvesting, and chronic obstructive pulmonary disease (COPD). The latter was defined as chronic lung disease (emphysema, chronic bronchitis) of any severity (FEV<sub>1</sub> &#x0003c;75% of predicted, and/or on chronic steroid or bronchodilator therapy) preoperatively diagnosed by a respiratory specialist [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p>Randomization of patients and assignment to each study group was performed immediately after the chest drains removal via a random number generator program. The study variables recorded for both groups were: the need for re-operation for mechanically induced sternum complications, the number of requests for analgesic supplementation, the quality of life as measured by the EQ-5D format [<xref ref-type="bibr" rid="CR14">14</xref>], which was administered to patients at the moment of discharge, the duration of hospitalization (in days), the number of patients that were re-admitted only for post-sternotomy mechanically induced complications at any time from the start of the study until the end of follow-up and their length of stay following re-admission (in days).</p><p>Being that this an monocentric study, no trial registry was created to perform our analysis; data were deposited in/or recovered from patients&#x02019; medical records.</p></sec><sec id="Sec4"><title>Sternum Closure</title><p>Routine sternum closure as per institutional practice was followed in all patients. Seven stainless-steel sternum wire sutures were passed though the sternum at approximately 1&#x000a0;cm apart on each side and were tied and twisted avoiding excessive tension. No patient underwent sternum closure by means of Robicsek&#x02019;s technique [<xref ref-type="bibr" rid="CR15">15</xref>]. Patients received an identical peri-operative prophylactic antibiotic regime with cefuroxime 3000&#x000a0;mg/day (adjusted accordingly with renal function) until the removal of the central venous line usually on the second post-operative day.</p><p>Any activity precaution after sternotomy was given to patients in according with well-established clinical and therapeutical practices.</p></sec><sec id="Sec5"><title>Analgesia Protocols</title><p>All patients in both groups received a similar analgesic protocol, which included 4&#x000a0;mg of morphine sulphate IV and 500&#x000a0;mg of paracetamol IV every 8&#x000a0;h with 4&#x000a0;mg of ondansetron IV every 12&#x000a0;h during the first 48&#x000a0;h post-operatively. Subsequently, the patients received 500&#x000a0;mg paracetamol IV every 8&#x000a0;h only. The additional on-demand analgesic supplementation to the standard analgesic protocol was 500&#x000a0;mg of paracetamol IV up to a maximum total of 2500&#x000a0;mg/day and afterwards 30&#x000a0;mg of ketorolac IV every 12&#x000a0;h. Pain levels were assessed every time a patient requested supplemental analgesia by using the visual analogue scale (VAS) to obtain a score [<xref ref-type="bibr" rid="CR16">16</xref>].</p></sec><sec id="Sec6"><title>Anatomical Recovery Evaluation</title><p>All patients underwent a routine anterior-posterior chest radiograph at discharge in order to assess anatomical sternum recovery by evaluating the sternotomy line. Findings such as a mid-sternum line of lucency &#x0003e;2&#x000a0;mm indicating sternum diastasis [<xref ref-type="bibr" rid="CR17">17</xref>], any sternum wire displacement, or any obvious interruption/dislocation were recorded. Given that the maximum dehiscence risk occurs during the first post-operative week, a single chest radiogram at discharge was deemed adequate to assess sternum diastasis and in addition to inspection of the thorax to evaluate the sternum instability and/or pain at coughing. The physician involved in evaluating the chest X-rays was blinded according to treatment group.</p><p>During the 90-day follow-up period after discharge, patients were monitored at their visits to the outpatient clinic or by telephone interviews focusing on sternal wound problems after discharge.</p></sec><sec id="Sec7"><title>Posthorax Support Vest</title><p>The Posthorax sternum support vest (Posthorax<sup>&#x000ae;</sup> sternum support vest; Epple, Inc., Vienna, Austria) is of a patented design with pressure and stabilization aimed specifically towards the sternum. It provides anterior-posterior stabilization of the thorax, instead of simple lateral compression, while holding the two halves of the sternum in place. Two pads placed longitudinally on each side of the sternum, ergonomically fitted for males and females, prevent intrinsic movement of the two sternum halves and serve as shock absorbers when the patient coughs or breathes deeply, and also support the sternum when mobilizing in and out of bed. Its design is non-restrictive so as to allow for maximal respiratory effort and expectoration without significantly contributing to respiratory complications such post-operative pneumonia. Moreover, the build-in individual sizing and upper strap supports stop the vest from sliding into and compressing the abdomen.</p></sec><sec id="Sec8"><title>Statistical Analysis</title><p>Continuous, normally distributed variables are presented as mean&#x000a0;&#x000b1;&#x000a0;standard deviation (SD). Categorical variables are expressed as absolute numbers and percentages. Comparisons between patient groups were performed using the <italic>&#x003c7;</italic>
<sup>2</sup> test and Fisher&#x02019;s exact test for categorical variables, while for continuous variable the unpaired <italic>t</italic> test or the Mann&#x02013;Whitney<italic> U</italic> test were used. In addition to direct group comparisons, subgroup comparisons according to individual variables of interest (age&#x000a0;&#x02265;&#x000a0;70, weight&#x000a0;&#x02265;&#x000a0;80&#x000a0;kg, BMI&#x000a0;&#x02265;&#x000a0;25, males, BIMA harvesting and those with COPD) were performed. <italic>p</italic> values less than 0.05 were considered statistically significant. For all statistical comparisons, the SPSS statistical software package for Windows (SPSS Inc., Chicago, IL, USA) was used.</p></sec></sec><sec id="Sec9"><title>Results</title><p>Patient clinical and operative characteristics are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The average number of requests for supplemental analgesia was lower in group A compared to group B but the difference did not reach statistical significance (1.6&#x000a0;&#x000b1;&#x000a0;0.4 vs. 2.0&#x000a0;&#x000b1;&#x000a0;0.5, <italic>p</italic>&#x000a0;=&#x000a0;NS) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). However, a subgroup analysis demonstrated a significant decrease in requests for supplemental analgesia in favor of group A in the following subgroups: those of age &#x0003c;70&#x000a0;years (1.4&#x000a0;&#x000b1;&#x000a0;0.1 vs. 2.3&#x000a0;&#x000b1;&#x000a0;0.2, <italic>p</italic>&#x000a0;=&#x000a0;0.002), males (1.3&#x000a0;&#x000b1;&#x000a0;0.2 vs. 2.1&#x000a0;&#x000b1;&#x000a0;0.1, <italic>p</italic>&#x000a0;=&#x000a0;0.005), patients with weight &#x02265;80&#x000a0;kg (1.7&#x000a0;&#x000b1;&#x000a0;0.1 vs. 3.6&#x000a0;&#x000b1;&#x000a0;0.2, <italic>p</italic>&#x000a0;=&#x000a0;0.001) or with a BMI &#x02265;25 (1.6&#x000a0;&#x000b1;&#x000a0;0.2 vs. 3.3&#x000a0;&#x000b1;&#x000a0;0.3, <italic>p</italic>&#x000a0;=&#x000a0;0.005), those with COPD (1.9&#x000a0;&#x000b1;&#x000a0;0.1 vs. 4.2&#x000a0;&#x000b1;&#x000a0;0.2, <italic>p</italic>&#x000a0;=&#x000a0;0.001), and those which underwent BIMA harvesting (1.4&#x000a0;&#x000b1;&#x000a0;0.1 vs. 3.2&#x000a0;&#x000b1;&#x000a0;0.2, <italic>p</italic>&#x000a0;=&#x000a0;0.001) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). The mean VAS pain score was significantly lower in group A than in group B (2.4&#x000a0;&#x000b1;&#x000a0;0.3 vs. 3.4&#x000a0;&#x000b1;&#x000a0;0.6, <italic>p</italic>&#x000a0;=&#x000a0;0.02), a difference which in the subgroup analysis was more pronounced in the following subgroups: those of age &#x0003c;70&#x000a0;years (2.4&#x000a0;&#x000b1;&#x000a0;0.2 vs. 4.3&#x000a0;&#x000b1;&#x000a0;0.4, <italic>p</italic>&#x000a0;=&#x000a0;0.001), males (2.2&#x000a0;&#x000b1;&#x000a0;0.1 vs. 3.6&#x000a0;&#x000b1;&#x000a0;0.3, <italic>p</italic>&#x000a0;=&#x000a0;0.005), patients with weight &#x02265;80&#x000a0;kg (2.1&#x000a0;&#x000b1;&#x000a0;0.3 vs. 4.2&#x000a0;&#x000b1;&#x000a0;0.1, <italic>p</italic>&#x000a0;=&#x000a0;0.001) or with BMI &#x02265;25 (2.3&#x000a0;&#x000b1;&#x000a0;0.2 vs. 4.3&#x000a0;&#x000b1;&#x000a0;0.2, <italic>p</italic>&#x000a0;=&#x000a0;0.001), those with COPD (3.1&#x000a0;&#x000b1;&#x000a0;0.5 vs. 4.7&#x000a0;&#x000b1;&#x000a0;0.6, <italic>p</italic>&#x000a0;=&#x000a0;0.002), and those which underwent BIMA harvesting (1.8&#x000a0;&#x000b1;&#x000a0;0.1 vs. 4.6&#x000a0;&#x000b1;&#x000a0;0.7, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001) (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Given the overall significant difference demonstrated that there was a significant reduction in pain scores between group A and group B across all types of surgery including coronary artery bypass grafting (CABG), (1.8&#x000a0;&#x000b1;&#x000a0;0.4 vs. 3.1&#x000a0;&#x000b1;&#x000a0;0.6, <italic>p</italic>&#x000a0;=&#x000a0;0.01), aortic valve replacement (AVR), (2.8&#x000a0;&#x000b1;&#x000a0;0.4 vs. 3.7&#x000a0;&#x000b1;&#x000a0;0.2, <italic>p</italic>&#x000a0;=&#x000a0;0.05), mitral valve replacement or repair (MVR), (2.4&#x000a0;&#x000b1;&#x000a0;0.2 vs. 3.4&#x000a0;&#x000b1;&#x000a0;0.4, <italic>p</italic>&#x000a0;=&#x000a0;0.02), ascending aorta/arch replacement (AAR), (2.8&#x000a0;&#x000b1;&#x000a0;0.3 vs. 3.6&#x000a0;&#x000b1;&#x000a0;1.1, <italic>p</italic>&#x000a0;=&#x000a0;0.05), and in combined surgery (2.3&#x000a0;&#x000b1;&#x000a0;0.3 vs. 3.4&#x000a0;&#x000b1;&#x000a0;0.3, <italic>p</italic>&#x000a0;=&#x000a0;0.02) (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The EQ-5D analysis of post-operative quality of life demonstrated significantly better results in terms of freedom of limitations in mobility (70 vs. 30%, <italic>p</italic>&#x000a0;=&#x000a0;0.001) and self care (73.5 vs. 46.4%, <italic>p</italic>&#x000a0;=&#x000a0;0.002), in totally limited activity (10.3 vs. 24.5%, <italic>p</italic>&#x000a0;=&#x000a0;0.005), in freedom from pain (43.2 vs. 10.3%, <italic>p</italic>&#x000a0;=&#x000a0;0.001), and in absence of anxiety (49.7 vs. 29.6%, <italic>p</italic>&#x000a0;=&#x000a0;0.05) in group A compared to group B (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). At discharge there were no cases of re-operation for mechanically induced sternum complication in group A vs. seven cases in group B (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). At discharge, a sternotomy stripe of lucency &#x0003e;2&#x000a0;mm was observed in seven patients in group A and in 31 patients in group B (4.5 vs. 20%, <italic>p</italic>&#x000a0;=&#x000a0;0.005), and a clear interruption/dislocation of the sternotomy line was observed in eight patients in group B and none in group A (5.2 vs. 0%) (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). The average days of in-hospital stay were significantly lower in group A compared to group B (7&#x000a0;&#x000b1;&#x000a0;2.7 vs. 12&#x000a0;&#x000b1;&#x000a0;3.4, <italic>p</italic>&#x000a0;=&#x000a0;0.02) (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). None of the patients in group A vs. three patients of group B developed post-operative pneumonia. In group B, 16 patients were re-admitted during the follow-up period for post-sternotomy mechanically induced complications vs. six patients in group A (3.9 vs. 10.3%, <italic>p</italic>&#x000a0;=&#x000a0;0.05) (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). The mean post re-admission hospital stay was significantly lower in group A (8&#x000a0;&#x000b1;&#x000a0;3.2&#x000a0;days) vs. group B (24&#x000a0;&#x000b1;&#x000a0;7&#x000a0;days, <italic>p</italic>&#x000a0;=&#x000a0;0.05) (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). There were no other complications of any kind reported with the usage of the Posthorax sternum support vest in group A patients. The mean follow-up was 2.4&#x000a0;&#x000b1;&#x000a0;2.1&#x000a0;years (range, 0.83&#x02013;5.25&#x000a0;years). Freedom from mechanical events at 5&#x000a0;years was 95.8&#x000a0;&#x000b1;&#x000a0;6.1 in GA and 84.7&#x000a0;&#x000b1;&#x000a0;5.3 in GB (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Patient clinical and operative characteristics (% or mean&#x000a0;&#x000b1;&#x000a0;SD)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Group A (<italic>n</italic>&#x000a0;=&#x000a0;155)</th><th align="left">Group B (<italic>n</italic>&#x000a0;=&#x000a0;155)</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">67.5&#x000a0;&#x000b1;&#x000a0;12.0</td><td align="left">70.4&#x000a0;&#x000b1;&#x000a0;14.0</td></tr><tr><td align="left">Male</td><td align="left">109 (70%)</td><td align="left">101 (65%)</td></tr><tr><td align="left">Female</td><td align="left">46 (30%)</td><td align="left">54 (35%)</td></tr><tr><td align="left">Weight (kg)</td><td align="left">84.3&#x000a0;&#x000b1;&#x000a0;17.2</td><td align="left">78.4&#x000a0;&#x000b1;&#x000a0;13.4</td></tr><tr><td align="left">BMI</td><td align="left">30.0&#x000a0;&#x000b1;&#x000a0;11.1</td><td align="left">28.0&#x000a0;&#x000b1;&#x000a0;8.2</td></tr><tr><td align="left">COPD</td><td align="left">57 (37%)</td><td align="left">61 (39%)</td></tr><tr><td align="left" colspan="3">Procedural subgroups</td></tr><tr><td align="left">&#x000a0;CABG</td><td align="left">74 (48%)</td><td align="left">70 (45%)</td></tr><tr><td align="left">&#x000a0;&#x000a0;1 graft</td><td align="left">24 (15%)</td><td align="left">25 (16%)</td></tr><tr><td align="left">&#x000a0;&#x000a0;2 grafts</td><td align="left">21 (14%)</td><td align="left">23 (14.8%)</td></tr><tr><td align="left">&#x000a0;&#x000a0;3 grafts</td><td align="left">28 (18%)</td><td align="left">24 (15%)</td></tr><tr><td align="left">&#x000a0;&#x000a0;4 grafts</td><td align="left">8 (5%)</td><td align="left">6 (4%)</td></tr><tr><td align="left">&#x000a0;LIMA graft</td><td align="left">41 (26%)</td><td align="left">43 (28%)</td></tr><tr><td align="left">&#x000a0;BIMA grafts</td><td align="left">40 (26%)</td><td align="left">35 (23%)</td></tr><tr><td align="left">&#x000a0;AVR or MVR</td><td align="left">57 (37%)</td><td align="left">60 (39%)</td></tr><tr><td align="left">&#x000a0;AAR</td><td align="left">8 (5%)</td><td align="left">7 (5%)</td></tr><tr><td align="left">&#x000a0;Combined surgery</td><td align="left">16 (10%)</td><td align="left">18 (12%)</td></tr></tbody></table><table-wrap-foot><p>
<italic>BMI</italic> body mass index, <italic>BIMA</italic> bilateral mammary arteries, <italic>COPD</italic> chronic obstructive pulmonary disease, <italic>AVR</italic> aortic valve replacement, <italic>CABG</italic> coronary artery bypass grafting, <italic>MVR</italic> mitral valve replacement or repair, <italic>LIMA</italic> left internal mammary artery, <italic>AAR</italic> ascending aorta and/or arch replacement</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Average number of requests for supplemental analgesia (mean&#x000a0;&#x000b1;&#x000a0;SD)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Group A (<italic>n</italic>&#x000a0;=&#x000a0;155)</th><th align="left">Group B (<italic>n</italic>&#x000a0;=&#x000a0;155)</th><th align="left">
<italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Overall mean</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.4</td><td char="&#x000b1;" align="char">2.0&#x000a0;&#x000b1;&#x000a0;0.5</td><td align="left">0.07</td></tr><tr><td align="left" colspan="4">Clinical subgroups</td></tr><tr><td align="left">&#x000a0;Age &#x02265;70</td><td char="&#x000b1;" align="char">1.8&#x000a0;&#x000b1;&#x000a0;0.7</td><td char="&#x000b1;" align="char">1.7&#x000a0;&#x000b1;&#x000a0;0.8</td><td align="left">0.085</td></tr><tr><td align="left">&#x000a0;Age &#x0003c;70</td><td char="&#x000b1;" align="char">1.4&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">2.3&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="left">0.002</td></tr><tr><td align="left" colspan="4">&#x000a0;Sex</td></tr><tr><td align="left">&#x000a0;&#x000a0;Male</td><td char="&#x000b1;" align="char">1.3&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">2.1&#x000a0;&#x000b1;&#x000a0;0.1</td><td align="left">0.005</td></tr><tr><td align="left">&#x000a0;&#x000a0;Female</td><td char="&#x000b1;" align="char">1.9&#x000a0;&#x000b1;&#x000a0;0.6</td><td char="&#x000b1;" align="char">1.9&#x000a0;&#x000b1;&#x000a0;0.9</td><td align="left">&#x02013;</td></tr><tr><td align="left">&#x000a0;Weight &#x02265;80&#x000a0;kg</td><td char="&#x000b1;" align="char">1.7&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">3.6&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="left">0.001</td></tr><tr><td align="left">&#x000a0;Weight &#x0003c;80&#x000a0;kg</td><td char="&#x000b1;" align="char">1.4&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.3</td><td align="left">0.066</td></tr><tr><td align="left">&#x000a0;BMI &#x02265;25</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">3.3&#x000a0;&#x000b1;&#x000a0;0.3</td><td align="left">0.005</td></tr><tr><td align="left">&#x000a0;BMI &#x0003c;25</td><td char="&#x000b1;" align="char">2.0&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">1.8&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="left">0.074</td></tr><tr><td align="left">&#x000a0;COPD</td><td char="&#x000b1;" align="char">1.9&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">4.2&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="left">0.001</td></tr><tr><td align="left" colspan="4">Procedural subgroups</td></tr><tr><td align="left">&#x000a0;CABG</td><td char="&#x000b1;" align="char">1.4&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.5</td><td align="left">0.082</td></tr><tr><td align="left">&#x000a0;&#x000a0;1 graft</td><td char="&#x000b1;" align="char">1.2&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">1.4&#x000a0;&#x000b1;&#x000a0;0.4</td><td align="left">0.073</td></tr><tr><td align="left">&#x000a0;&#x000a0;2 grafts</td><td char="&#x000b1;" align="char">1.4&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">1.8&#x000a0;&#x000b1;&#x000a0;0.6</td><td align="left">0.065</td></tr><tr><td align="left">&#x000a0;&#x000a0;3 grafts</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.4</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.5</td><td align="left">&#x02013;</td></tr><tr><td align="left">&#x000a0;&#x000a0;4 grafts</td><td char="&#x000b1;" align="char">1.4&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.5</td><td align="left">0.082</td></tr><tr><td align="left">&#x000a0;LIMA graft</td><td char="&#x000b1;" align="char">1.7&#x000a0;&#x000b1;&#x000a0;0.6</td><td char="&#x000b1;" align="char">2.3&#x000a0;&#x000b1;&#x000a0;0.7</td><td align="left">0.055</td></tr><tr><td align="left">&#x000a0;BIMA grafts</td><td char="&#x000b1;" align="char">1.4&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">3.2&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="left">0.001</td></tr><tr><td align="left">&#x000a0;AVR</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">1.9&#x000a0;&#x000b1;&#x000a0;0.4</td><td align="left">0.070</td></tr><tr><td align="left">&#x000a0;MVR</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.7</td><td char="&#x000b1;" align="char">1.7&#x000a0;&#x000b1;&#x000a0;0.3</td><td align="left">0.089</td></tr><tr><td align="left">&#x000a0;AAR</td><td char="&#x000b1;" align="char">1.9&#x000a0;&#x000b1;&#x000a0;0.4</td><td char="&#x000b1;" align="char">2.1&#x000a0;&#x000b1;&#x000a0;0.7</td><td align="left">0.078</td></tr></tbody></table></table-wrap>
<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Visual analog scale (VAS) pain scores (mean&#x000a0;&#x000b1;&#x000a0;SD)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Group A (<italic>n</italic>&#x000a0;=&#x000a0;155)</th><th align="left">Group B (<italic>n</italic>&#x000a0;=&#x000a0;155)</th><th align="left">
<italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Overall mean</td><td char="&#x000b1;" align="char">2.4&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">3.4&#x000a0;&#x000b1;&#x000a0;0.6</td><td align="left">0.02</td></tr><tr><td align="left" colspan="4">Clinical subgroups</td></tr><tr><td align="left">&#x000a0;Age &#x02265;70</td><td char="&#x000b1;" align="char">2.4&#x000a0;&#x000b1;&#x000a0;0.4</td><td char="&#x000b1;" align="char">2.5&#x000a0;&#x000b1;&#x000a0;0.8</td><td align="left">0.086</td></tr><tr><td align="left">&#x000a0;Age &#x0003c;70</td><td char="&#x000b1;" align="char">2.4&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">4.3&#x000a0;&#x000b1;&#x000a0;0.4</td><td align="left">0.001</td></tr><tr><td align="left" colspan="4">&#x000a0;Sex</td></tr><tr><td align="left">&#x000a0;&#x000a0;Male</td><td char="&#x000b1;" align="char">2.2&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">3.6&#x000a0;&#x000b1;&#x000a0;0.3</td><td align="left">0.005</td></tr><tr><td align="left">&#x000a0;&#x000a0;Female</td><td char="&#x000b1;" align="char">2.6&#x000a0;&#x000b1;&#x000a0;0.5</td><td char="&#x000b1;" align="char">3.2&#x000a0;&#x000b1;&#x000a0;0.9</td><td align="left">0.059</td></tr><tr><td align="left">&#x000a0;Weight &#x02265;80&#x000a0;kg</td><td char="&#x000b1;" align="char">2.1&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">4.2&#x000a0;&#x000b1;&#x000a0;0.1</td><td align="left">0.001</td></tr><tr><td align="left">&#x000a0;Weight &#x0003c;80&#x000a0;kg</td><td char="&#x000b1;" align="char">2.7&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">2.6&#x000a0;&#x000b1;&#x000a0;1.1</td><td align="left">0.071</td></tr><tr><td align="left">&#x000a0;BMI &#x02265;25</td><td char="&#x000b1;" align="char">2.3&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">4.3&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="left">0.001</td></tr><tr><td align="left">&#x000a0;BMI &#x0003c;25</td><td char="&#x000b1;" align="char">2.5&#x000a0;&#x000b1;&#x000a0;0.4</td><td char="&#x000b1;" align="char">2.5&#x000a0;&#x000b1;&#x000a0;1.0</td><td align="left">&#x02013;</td></tr><tr><td align="left">&#x000a0;COPD</td><td char="&#x000b1;" align="char">3.1&#x000a0;&#x000b1;&#x000a0;0.5</td><td char="&#x000b1;" align="char">4.7&#x000a0;&#x000b1;&#x000a0;0.6</td><td align="left">0.002</td></tr><tr><td align="left" colspan="4">Procedural subgroups</td></tr><tr><td align="left">&#x000a0;CABG</td><td char="&#x000b1;" align="char">1.8&#x000a0;&#x000b1;&#x000a0;0.4</td><td char="&#x000b1;" align="char">3.1&#x000a0;&#x000b1;&#x000a0;0.6</td><td align="left">0.01</td></tr><tr><td align="left">&#x000a0;&#x000a0;1 graft</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">2.3&#x000a0;&#x000b1;&#x000a0;1.0</td><td align="left">0.061</td></tr><tr><td align="left">&#x000a0;&#x000a0;2 grafts</td><td char="&#x000b1;" align="char">2.0&#x000a0;&#x000b1;&#x000a0;0.6</td><td char="&#x000b1;" align="char">2.8&#x000a0;&#x000b1;&#x000a0;1.2</td><td align="left">0.057</td></tr><tr><td align="left">&#x000a0;&#x000a0;3 grafts</td><td char="&#x000b1;" align="char">1.7&#x000a0;&#x000b1;&#x000a0;0.8</td><td char="&#x000b1;" align="char">2.4&#x000a0;&#x000b1;&#x000a0;0.4</td><td align="left">0.072</td></tr><tr><td align="left">&#x000a0;&#x000a0;4 grafts</td><td char="&#x000b1;" align="char">1.9&#x000a0;&#x000b1;&#x000a0;0.6</td><td char="&#x000b1;" align="char">2.9&#x000a0;&#x000b1;&#x000a0;0.8</td><td align="left">0.05</td></tr><tr><td align="left">&#x000a0;LIMA graft</td><td char="&#x000b1;" align="char">1.8&#x000a0;&#x000b1;&#x000a0;0.7</td><td char="&#x000b1;" align="char">1.6&#x000a0;&#x000b1;&#x000a0;0.5</td><td align="left">0.077</td></tr><tr><td align="left">&#x000a0;BIMA grafts</td><td char="&#x000b1;" align="char">1.8&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">4.6&#x000a0;&#x000b1;&#x000a0;0.7</td><td align="left">0.001</td></tr><tr><td align="left">&#x000a0;AVR</td><td char="&#x000b1;" align="char">2.8&#x000a0;&#x000b1;&#x000a0;0.4</td><td char="&#x000b1;" align="char">3.7&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="left">0.05</td></tr><tr><td align="left">&#x000a0;MVR</td><td char="&#x000b1;" align="char">2.4&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">3.4&#x000a0;&#x000b1;&#x000a0;0.4</td><td align="left">0.02</td></tr><tr><td align="left">&#x000a0;AAR</td><td char="&#x000b1;" align="char">2.8&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">3.6&#x000a0;&#x000b1;&#x000a0;1.1</td><td align="left">0.05</td></tr><tr><td align="left">&#x000a0;Combined surgery</td><td char="&#x000b1;" align="char">2.3&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">3.4&#x000a0;&#x000b1;&#x000a0;0.3</td><td align="left">0.02</td></tr></tbody></table><table-wrap-foot><p>For the legend, see Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>
</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>EQ-5D category distribution (<italic>n</italic>%)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Group A (<italic>n</italic>&#x000a0;=&#x000a0;155)</th><th align="left">Group B (<italic>n</italic>&#x000a0;=&#x000a0;155)</th><th align="left">
<italic>p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="4">Mobility</td></tr><tr><td align="left">&#x000a0;Free of limitations</td><td align="left">108 (70%)</td><td char="(" align="char">47 (30%)</td><td align="left">0.001</td></tr><tr><td align="left">&#x000a0;Partially limited</td><td align="left">47 (30%)</td><td char="(" align="char">62 (40%)</td><td align="left">0.058</td></tr><tr><td align="left">&#x000a0;Totally limited</td><td align="left">0</td><td char="(" align="char">46 (30%)</td><td align="left">&#x02013;</td></tr><tr><td align="left" colspan="4">Self care</td></tr><tr><td align="left">&#x000a0;Free of limitations</td><td align="left">114 (74%)</td><td char="(" align="char">72 (46%)</td><td align="left">0.002</td></tr><tr><td align="left">&#x000a0;Partially limited</td><td align="left">41 (27%)</td><td char="(" align="char">44 (28%)</td><td align="left">0.32</td></tr><tr><td align="left">&#x000a0;Totally limited</td><td align="left">0</td><td char="(" align="char">39 (25%)</td><td align="left">&#x02013;</td></tr><tr><td align="left" colspan="4">Usual activities</td></tr><tr><td align="left">&#x000a0;Free of limitations</td><td align="left">77 (50%)</td><td char="(" align="char">61 (39%)</td><td align="left">0.062</td></tr><tr><td align="left">&#x000a0;Partially limited</td><td align="left">62 (40%)</td><td char="(" align="char">56 (36%)</td><td align="left">0.12</td></tr><tr><td align="left">&#x000a0;Totally limited</td><td align="left">16 (10%)</td><td char="(" align="char">38 (25%)</td><td align="left">0.005</td></tr><tr><td align="left" colspan="4">Pain/discomfort</td></tr><tr><td align="left">&#x000a0;Absent</td><td align="left">67 (43%)</td><td char="(" align="char">16 (10%)</td><td align="left">0.001</td></tr><tr><td align="left">&#x000a0;Moderate</td><td align="left">88 (57%)</td><td char="(" align="char">102 (66%)</td><td align="left">0.24</td></tr><tr><td align="left">&#x000a0;Extreme</td><td align="left">0</td><td char="(" align="char">37 (24%)</td><td align="left">&#x02013;</td></tr><tr><td align="left" colspan="4">Anxiety/depression</td></tr><tr><td align="left">&#x000a0;Absent</td><td align="left">77 (50%)</td><td char="(" align="char">46 (27%)</td><td align="left">0.05</td></tr><tr><td align="left">&#x000a0;Moderate</td><td align="left">78 (50%)</td><td char="(" align="char">87 (56%)</td><td align="left">0.19</td></tr><tr><td align="left">&#x000a0;Extreme</td><td align="left">0</td><td char="(" align="char">22 (14%)</td><td align="left">&#x02013;</td></tr></tbody></table></table-wrap>
<table-wrap id="Tab5"><label>Table&#x000a0;5</label><caption><p>Outcomes (number event or mean&#x000a0;&#x000b1;&#x000a0;SD)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Group A (<italic>n</italic>&#x000a0;=&#x000a0;155)</th><th align="left">Group B (<italic>n</italic>&#x000a0;=&#x000a0;155)</th><th align="left">
<italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Post operative length of stay (days)</td><td align="left">7&#x000a0;&#x000b1;&#x000a0;2.7</td><td align="left">12&#x000a0;&#x000b1;&#x000a0;3.4</td><td align="left">0.02</td></tr><tr><td align="left">Re-admission for mechanical complications</td><td align="left">6</td><td align="left">16</td><td align="left">0.05</td></tr><tr><td align="left">Re-operation for mechanical complications</td><td align="left">0</td><td align="left">7</td><td align="left">&#x02013;</td></tr><tr><td align="left">Length of stay following re-admission</td><td align="left">8&#x000a0;&#x000b1;&#x000a0;3.2</td><td align="left">24&#x000a0;&#x000b1;&#x000a0;7.0</td><td align="left">0.05</td></tr><tr><td align="left">Sternotomy line &#x0003e;2&#x000a0;mm at discharges</td><td align="left">7</td><td align="left">31</td><td align="left">0.005</td></tr><tr><td align="left">Dislocation of sternotomy line</td><td align="left">0</td><td align="left">8</td><td align="left">&#x02013;</td></tr><tr><td align="left">Follow-up (mean, 2.4&#x000a0;&#x000b1;&#x000a0;2.1&#x000a0;years, range, 0.83&#x02013;5.25&#x000a0;years)<break/>5&#x000a0;years freedom from mechanical events (%)</td><td align="left">95.8&#x000a0;&#x000b1;&#x000a0;6.1</td><td align="left">84.7&#x000a0;&#x000b1;&#x000a0;5.3</td><td align="left">0.001</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec10"><title>Discussion</title><p>The Posthorax vest is the latest technological generation of sternum support corsets [<xref ref-type="bibr" rid="CR18">18</xref>]. It has been designed to stabilize the sternum following sternotomy so as to avoid excessive stress on the sternum wires during bone healing [<xref ref-type="bibr" rid="CR17">17</xref>]. It differs from other previous vest designs because its structure is open in the front and is not based on a circumferential elastic band design making it less restrictive [<xref ref-type="bibr" rid="CR18">18</xref>]. This open structure is also more hygienic, as it avoids compression and contamination of the skin wound. The non-elastic band structure avoids harmful continuous compression on the thorax and interference with respiratory effort and only provides support during excessive chest stress such as when coughing, mobilizing, or performing rehabilitation exercises [<xref ref-type="bibr" rid="CR18">18</xref>]. In other words, the patient&#x02019;s chest is free to move during breathing and is only supported during excessive or non-physiological movement, thus reducing the potential risk of respiratory complications. None of the patients who utilized the Posthorax support vest in our series developed post-operative pneumonia or any other kind of complications associated with its use. Our findings concerning the incidence of respiratory complications with Posthorax support vest adoption is not statistically significant. Statistically significant clinical advantages were observed in the group of patients that used the Posthorax support vest following sternotomy, such as less mechanical complications, better sternal healing, lower hospitalization, less pain and lower analgesic medication requirements, better comfort, and earlier mobilization and autonomy. These clinical improvements may be attributed to the improved sternum stability in group A that is provided by the Posthorax support vest without limitation on breathing and this can be translated in better patient comfort and mobility and lower incidence of mechanically induced sternum complications, but quite importantly in our &#x0201c;economic conscious&#x0201d; age can mean lower associated healthcare costs. Our findings are supported by other randomized studies from the literature [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. However, these studies are multicentric and included infective and non-infective sternal complications and furthermore they did not do an extensive subgroup analysis on patients with a high risk for sternal complications. As recently reported by Heilmann et al. [<xref ref-type="bibr" rid="CR19">19</xref>], superficial healing disorders occur in 3.3% of unselected patients after sternotomy for cardiac surgery, while 2.5% developed deep wound complications and 7.9% of them died in-hospital. No pathogen was identified and the wound appeared uninfected in 21% of all deep complications or 0.05% of all patients.</p><sec id="Sec11"><title>Study Limitations</title><p>The study presents a number of limitations: firstly, we used EQ-5D format only as a descriptive tool because the time of observation of the study has been limited only to the hospital stay in order to eliminate bias related with differences in managing or behavior of patients after discharge from the hospital. To overcome this problem, we assumed the EQ-5D of the control group as the baseline. Furthermore, the use of baseline data inside the groups is not proper if we consider the fast changes of health status during the early postoperative period, a factor that makes EQ&#x000a0;5 as not reliable. Another limitation might be the antalgic protocol of the study. Our institution has not arbitrarily implemented this protocol, but it followed the directives of the &#x0201c;Hospital without pain&#x0201d; project that has been established by the Italian National Health Service (NHS) within all specialties for all hospitals. A further potential limitation is the exclusion of all events at risk for infections and mediastinitis. It should, however, be stressed that the end point of the study is the prevention of mechanical complications of sternotomy with this vest and it has been adopted because the vest only acts mechanically. Thus, we have decided to eliminate this potential bias for powering the study. As mediastinitis is now a rare complication in cardiac surgery, the exclusion of mediastinitis is not a significant limitation of the study when we consider the dimension of our series. Finally, the lack of information regarding the techniques of sternal closure, we feel this aspect is not a significant limitation because both groups have been managed by the same surgical staff so that distributions of surgeon-dependent and patient-dependent criteria have been &#x0201c;de facto&#x0201d; random. Furthermore, it should be considered that in the same patient, the surgeon could use both kinds of wires in different segments of the sternotomy for technical reasons.</p><p>To follow patients in their use of the Posthorax vest during 90&#x000a0;days after discharge is very difficult and this may be considered another important limitation point. Indeed, during this period we have asserted the continuous use of the vest by outpatient visit or telephone interview. Of course, this procedure may be considered to be affected by limited veracity; however, the results obtained in the present study seem to indicate a continuous use of the vest by the patients.</p></sec></sec><sec id="Sec12"><title>Conclusions</title><p>The data of the present study show that mechanical sternal complications play a significant role in the genesis of poststernotomy complications and confirm they remain a challenge to cardiac surgery so that more efforts seem mandatory to decrease their significant morbidity and the costs of prolonged treatment. The original design of this study allows to evaluate for the first time without bias the effectiveness of this new sternal support corset to prevent mechanical sternal complications, to reduce pain and hospitalization, and to increase the quality of life in the postoperative period.</p></sec></body><back><fn-group><fn><p>In memory of Marcus Vinicius Ferraz, dear friend, colleague and gentleman.</p></fn><fn><p><bold>Enhanced content</bold></p><p>To view enhanced content for this article go to <ext-link ext-link-type="uri" xlink:href="http://www.medengine.com/Redeem/DA47F06002A3D3E3">http://www.medengine.com/Redeem/DA47F06002A3D3E3</ext-link>.</p></fn></fn-group><ack><title>Acknowledgements</title><p>No funding or sponsorship was received for this study or publication of this article. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published.</p><sec id="FPar1"><title>Disclosures</title><p>Philippe P. Caimmi, Maurizio Sabbatini, Emmanouil I. Kapetanakis, Silvia Cantone, Marcus V. Ferraz, Mario Cannas and Ugo F. Tesler have nothing to disclose.</p></sec><sec id="FPar2"><title>Compliance with Ethics Guidelines</title><p>All procedures followed were in accordance with the ethical standards of the responsible national and institutional committee on human experimentation and with the Helsinki Declaration of 1964, as revised in 2013. Informed consent was obtained from all patients for being included in the study.</p></sec><sec id="FPar3"><title>Data Availability</title><p>The datasets generated and analyzed during the current study are available from first author of the study (P. Caimmi: pcaimmi@gmail.com) or from corresponding author on reasonable request.</p></sec><sec id="d29e1900"><title>Open Access</title><p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loop</surname><given-names>FD</given-names></name><name><surname>Lytle</surname><given-names>BW</given-names></name><name><surname>Cosgrove</surname><given-names>DM</given-names></name><name><surname>Mahfood</surname><given-names>S</given-names></name><name><surname>McHenry</surname><given-names>MC</given-names></name><name><surname>Goormastic</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sternum wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity and cost of care</article-title><source>Ann Thorac Surg</source><year>1990</year><volume>49</volume><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/0003-4975(90)90136-T</pub-id><pub-id pub-id-type="pmid">2306138</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olbrecht</surname><given-names>VA</given-names></name><name><surname>Barreiro</surname><given-names>CJ</given-names></name><name><surname>Bonde</surname><given-names>PN</given-names></name><name><surname>Williams</surname><given-names>JA</given-names></name><name><surname>Baumgartner</surname><given-names>WA</given-names></name><name><surname>Gott</surname><given-names>VL</given-names></name><etal/></person-group><article-title>Clinical outcomes of non-infectious sternum dehiscence after median sternotomy</article-title><source>Ann Thorac Surg</source><year>2006</year><volume>82</volume><fpage>902</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2006.04.058</pub-id><pub-id pub-id-type="pmid">16928505</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speir</surname><given-names>AM</given-names></name><name><surname>Kasirajan</surname><given-names>V</given-names></name><name><surname>Barnett</surname><given-names>SD</given-names></name><name><surname>Fonner</surname><given-names>E</given-names><suffix>Jr</suffix></name></person-group><article-title>Additive costs of post-operative complications for isolated coronary artery bypass grafting patients in Virginia</article-title><source>Ann Thorac Surg</source><year>2009</year><volume>88</volume><fpage>40</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2009.03.076</pub-id><pub-id pub-id-type="pmid">19559186</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postel</surname><given-names>M</given-names></name><name><surname>Frank</surname><given-names>PN</given-names></name><name><surname>Barry</surname><given-names>T</given-names></name><name><surname>Satou</surname><given-names>N</given-names></name><name><surname>Shemin</surname><given-names>R</given-names></name><name><surname>Benharash</surname><given-names>P</given-names></name></person-group><article-title>The cost of preventing re-admissions: why surgeons should lead the effort</article-title><source>Am Surg</source><year>2014</year><volume>80</volume><fpage>1003</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">25264648</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyerson</surname><given-names>J</given-names></name><name><surname>Thelin</surname><given-names>S</given-names></name><name><surname>Gordh</surname><given-names>T</given-names></name><name><surname>Karlsten</surname><given-names>R</given-names></name></person-group><article-title>The incidence of chronic post-sternotomy pain after cardiac surgery&#x02014;a prospective study</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><fpage>940</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1034/j.1399-6576.2001.450804.x</pub-id><pub-id pub-id-type="pmid">11576043</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>J</given-names></name><name><surname>Drury</surname><given-names>N</given-names></name><name><surname>Poobalan</surname><given-names>AS</given-names></name><name><surname>Jeffrey</surname><given-names>RR</given-names></name><name><surname>Smith</surname><given-names>WC</given-names></name><name><surname>Chambers</surname><given-names>WA</given-names></name></person-group><article-title>The prevalence of chronic chest and leg pain following cardiac surgery: a historical cohort study</article-title><source>Pain</source><year>2003</year><volume>104</volume><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(03)00017-4</pub-id><pub-id pub-id-type="pmid">12855337</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raksamani</surname><given-names>K</given-names></name><name><surname>Wongkornrat</surname><given-names>W</given-names></name><name><surname>Siriboon</surname><given-names>P</given-names></name><name><surname>Pantisawat</surname><given-names>N</given-names></name></person-group><article-title>Pain management after cardiac surgery: are we underestimating post sternotomy pain?</article-title><source>J Med Assoc Thai</source><year>2013</year><volume>96</volume><fpage>824</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">24319854</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santarpino</surname><given-names>G</given-names></name><name><surname>Pfeiffer</surname><given-names>S</given-names></name><name><surname>Concistr&#x000e9;</surname><given-names>G</given-names></name><name><surname>Fischlein</surname><given-names>T</given-names></name></person-group><article-title>Sternum wound dehiscence from intense coughing in a cardiac surgery patient: could it be prevented?</article-title><source>G Chir</source><year>2013</year><volume>34</volume><fpage>112</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">23660161</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorlitzer</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>F</given-names></name><name><surname>Pfeiffer</surname><given-names>S</given-names></name><name><surname>Folkmann</surname><given-names>S</given-names></name><name><surname>Meinhart</surname><given-names>J</given-names></name><name><surname>Fischlein</surname><given-names>T</given-names></name><etal/></person-group><article-title>A prospective randomized multicenter trial shows improvement of sternum related complications in cardiac surgery with the Posthorax support vest</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2010</year><volume>10</volume><fpage>714</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1510/icvts.2009.223305</pub-id><pub-id pub-id-type="pmid">20103509</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorlitzer</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>F</given-names></name><name><surname>Pfeiffer</surname><given-names>S</given-names></name><name><surname>Folkmann</surname><given-names>S</given-names></name><name><surname>Meinhart</surname><given-names>J</given-names></name><name><surname>Fischlein</surname><given-names>T</given-names></name><etal/></person-group><article-title>Prevention of sternal wound complications after sternotomy: results of a large prospective randomized multicentre trial</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2013</year><volume>17</volume><fpage>515</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1093/icvts/ivt240</pub-id><pub-id pub-id-type="pmid">23760221</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celik</surname><given-names>S</given-names></name><name><surname>Kirbas</surname><given-names>A</given-names></name><name><surname>Gurer</surname><given-names>O</given-names></name><name><surname>Yildiz</surname><given-names>Y</given-names></name><name><surname>Isik</surname><given-names>O</given-names></name></person-group><article-title>Sternum dehiscence in patients with moderate and severe chronic obstructive pulmonary disease undergoing cardiac surgery: the value of supportive thorax vests</article-title><source>J Thorac Cardiovasc Surg</source><year>2011</year><volume>141</volume><fpage>1398</fpage><lpage>1402</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2011.01.042</pub-id><pub-id pub-id-type="pmid">21377699</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><article-title>The CONSORT statement revised recommendations for improving the quality of reports of parallel-group randomized trials</article-title><source>Ann Intern Med</source><year>2001</year><volume>134</volume><fpage>657</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-134-8-200104170-00011</pub-id><pub-id pub-id-type="pmid">11304106</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risnes</surname><given-names>I</given-names></name><name><surname>Abdelnoor</surname><given-names>M</given-names></name><name><surname>Almdahl</surname><given-names>SM</given-names></name><name><surname>Svennevig</surname><given-names>JL</given-names></name></person-group><article-title>Mediastinitis after coronary artery bypass grafting risk factors and long-term survival</article-title><source>Ann Thorac Surg</source><year>2010</year><volume>89</volume><fpage>1502</fpage><lpage>1509</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2010.02.038</pub-id><pub-id pub-id-type="pmid">20417768</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>R</given-names></name></person-group><article-title>EuroQoL: the current state of play</article-title><source>Health Policy</source><year>1996</year><volume>37</volume><fpage>53</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/0168-8510(96)00822-6</pub-id><pub-id pub-id-type="pmid">10158943</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robicsek</surname><given-names>F</given-names></name><name><surname>Daugherty</surname><given-names>HK</given-names></name><name><surname>Cook</surname><given-names>JW</given-names></name></person-group><article-title>The prevention and treatment of sternum separation following open-heart surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>1977</year><volume>73</volume><fpage>267</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">319304</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>SL</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>McQuay</surname><given-names>HJ</given-names></name></person-group><article-title>The visual analogue pain intensity scale: what is moderate pain in millimetres?</article-title><source>Pain</source><year>1997</year><volume>72</volume><fpage>95</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(97)00005-5</pub-id><pub-id pub-id-type="pmid">9272792</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vestergaard</surname><given-names>RF</given-names></name><name><surname>Jensen</surname><given-names>H</given-names></name><name><surname>Vind-Kezunovic</surname><given-names>S</given-names></name><name><surname>Jakobsen</surname><given-names>T</given-names></name><name><surname>S&#x000f8;balle</surname><given-names>K</given-names></name><name><surname>Hasenkam</surname><given-names>JM</given-names></name></person-group><article-title>Bone healing after median sternotomy: a comparison of two hemostatic devices</article-title><source>J Cardiothorac Surg</source><year>2010</year><volume>5</volume><fpage>117</fpage><pub-id pub-id-type="doi">10.1186/1749-8090-5-117</pub-id><pub-id pub-id-type="pmid">21106051</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorlitzer</surname><given-names>M</given-names></name><name><surname>Folkmann</surname><given-names>S</given-names></name><name><surname>Meinhart</surname><given-names>J</given-names></name><name><surname>Poslussny</surname><given-names>P</given-names></name><name><surname>Thalmann</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>G</given-names></name><etal/></person-group><article-title>A newly designed thorax support vest prevents sternum instability after median sternotomy</article-title><source>Eur J Cardiothorac Surg</source><year>2009</year><volume>36</volume><fpage>335</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.ejcts.2009.01.038</pub-id><pub-id pub-id-type="pmid">19272785</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heilmann</surname><given-names>C</given-names></name><name><surname>Stahl</surname><given-names>R</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Sukhodolya</surname><given-names>T</given-names></name><name><surname>Siepe</surname><given-names>M</given-names></name><name><surname>Olschewski</surname><given-names>M</given-names></name><etal/></person-group><article-title>Wound complications after median sternotomy: a single-centre study</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2013</year><volume>16</volume><fpage>643</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1093/icvts/ivs554</pub-id><pub-id pub-id-type="pmid">23355648</pub-id></element-citation></ref></ref-list></back></article>